Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Cellular and Molecular Biology Letters

Editor-in-Chief: /


IMPACT FACTOR 2016: 1.260
5-year IMPACT FACTOR: 1.506

CiteScore 2016: 1.56

SCImago Journal Rank (SJR) 2016: 0.615
Source Normalized Impact per Paper (SNIP) 2016: 0.470

Online
ISSN
1689-1392
See all formats and pricing
More options …
Volume 16, Issue 3 (Sep 2011)

Effects of Clostridium perfringens enterotoxin via claudin-4 on normal human pancreatic duct epithelial cells and cancer cells

Hiroshi Yamaguchi / Takashi Kojima / Tatsuya Ito / Daisuke Kyuno / Yasutoshi Kimura / Masafumi Imamura / Koichi Hirata / Norimasa Sawada
Published Online: 2011-07-23 | DOI: https://doi.org/10.2478/s11658-011-0014-z

Abstract

The tight junction protein claudin-4 is frequently overexpressed in pancreatic cancer, and is also a receptor for Clostridium perfringens enterotoxin (CPE). The cytotoxic effects of CPE are thought to be useful as a novel therapeutic tool for pancreatic cancer. However, the responses to CPE via claudin-4 remain unknown in normal human pancreatic duct epithelial (HPDE) cells. We introduced the human telomerase reverse transcriptase (hTERT) gene into HPDE cells in primary culture as a model of normal HPDE cells in vitro. hTERT-HPDE cells treated with or without 10% FBS and pancreatic cancer cell lines PANC-1, BXPC3, HPAF-II and HPAC were treated with CPE. In Western blotting, the expression of claudin-4 protein in hTERT-HPDE cells treated with 10% FBS was as high as it was in all of the pancreatic cancer cell lines. In hTERT-HPDE cells with or without 10% FBS, cytotoxicity was not observed at any concentration of CPE, whereas in all pancreatic cancer cell lines, CPE had a dose-dependent cytotoxic effect. In hTERT-HPDE cells with 10% FBS, claudin-4 was localized in the apical-most regions, where there are tight junction areas, in which in all pancreatic cancer cell lines claudin-4 was found not only in the apical-most regions but also at basolateral membranes. In hTERT-HPDE cells with 10% FBS after treatment with CPE, downregulation of barrier function and claudin-4 expression at the membranes was observed. In HPAC cells, the sensitivity to CPE was significantly decreased by knockdown of claudin-4 expression using siRNA compared to the control. These findings suggest that, in normal HPDE cells, the lack of toxicity of CPE was probably due to the localization of claudin-4, which is different from that of pancreatic cancer cells. hTERT-HPDE cells in this culture system may be a useful model of normal HPDE cells not only for physiological regulation of claudin-4 expression but also for developing safer and more effective therapeutic methods targeting claudin-4 in pancreatic cancer.

Keywords: Tight junction; Claudin-4; CPE; Human pancreatic duct epithelial cells; Human pancreatic cancer cells

  • [1] Morin, P.J. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res. 65 (2005) 9603–9606. http://dx.doi.org/10.1158/0008-5472.CAN-05-2782CrossrefGoogle Scholar

  • [2] Tsukita, S., Yamazaki, Y., Katsuno, T., Tamura, A. and Tsukita, S. Tight junction-based epithelial microenvironment and cell proliferation. Oncogene 27 (2008) 6930–6938. http://dx.doi.org/10.1038/onc.2008.344CrossrefWeb of ScienceGoogle Scholar

  • [3] Tsukita, S., Furuse, M. and Itoh, M. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2 (2001) 285–293. http://dx.doi.org/10.1038/35067088CrossrefGoogle Scholar

  • [4] Fujita, K., Katahira, J., Horiguchi, Y., Sonoda, N., Furuse, M. and Tsukita, S. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett. 476 (2000) 258–261. http://dx.doi.org/10.1016/S0014-5793(00)01744-0CrossrefGoogle Scholar

  • [5] McClane, B.A. and Chakrabarti, G. New insights into the cytotoxic mechanisms of Clostridium perfringens enterotoxin. Anaerobe 10 (2004) 107–114. http://dx.doi.org/10.1016/j.anaerobe.2003.11.004CrossrefGoogle Scholar

  • [6] Michl, P., Buchholz, M., Rolke, M., Kunsch, S., Löhr, M., McClane, B., Tsukita, S., Leder, G., Adler, G. and Gress, T.M. Claudin-4: a new target for pancreatic cancer treatment using Clostridium Perfringens enterotoxin. Gastroenterology 121 (2001) 678–684. http://dx.doi.org/10.1053/gast.2001.27124CrossrefGoogle Scholar

  • [7] Katahira, J., Sugiyama, H,, Inoue, N., Horiguchi, Y., Matsuda, M. and Sugimoto, N. Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J. Biol. Chem. 272 (1997) 26652–26658. http://dx.doi.org/10.1074/jbc.272.42.26652CrossrefGoogle Scholar

  • [8] Yamaguchi, H., Kojima, T., Ito, T., Kimura, Y., Imamura, M., Son, S., Koizumi, J., Murata, M., Nagayama, M., Nobuoka, T., Tanaka, S., Hirata, K. and Sawada, N. Transcriptional control of tight junction proteins via a PKC signal pathway in hTERT-transfected human pancreatic duct epithelial cells. Am. J. Pathol. 177 (2010) 698–712. http://dx.doi.org/10.2353/ajpath.2010.091226CrossrefWeb of ScienceGoogle Scholar

  • [9] Kojima, T., Fuchimoto, J., Takasawa, A., Yamaguchi, H., Ito, T., Ninomiya, T., Kikuchi, S., Ogasawara, N., Ohkuni, T., Masaki, T., Hirata, K., Himi, T. and Sawada, N. c-Jun N-terminal kinase is largely involved in the regulation of tricellular tight junctions via tricellulin in human pancreatic duct epithelial cells. J. Cell. Physiol. 225 (2010) 720–733. http://dx.doi.org/10.1002/jcp.22273CrossrefWeb of ScienceGoogle Scholar

  • [10] Deer, E.L., González-Hernández, J., Coursen, J.D., Shea, J.E., Ngatia, J., Scaife, C.L., Firpo, M.A. and Mulvihill, S.J. Phenotype and genotype of pancreatic cancer cell lines. Pancreas 39 (2010) 425–435. http://dx.doi.org/10.1097/MPA.0b013e3181c15963Web of ScienceCrossrefGoogle Scholar

  • [11] 11 Winkler, L., Gehring, C., Wenzel, A., Müller, S.L., Piehl, C., Krause, G., Blasig, I.E. and Piontek, J. Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3. J. Biol. Chem. 284 (2009) 18863–18872. http://dx.doi.org/10.1074/jbc.M109.008623Web of ScienceGoogle Scholar

  • [12] Sonoda, N., Furuse, M., Sasaki, H., Yonemura, S., Katahira, J., Horiguchi, Y. and Tsukita, S. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier. J. Cell Biol. 147 (1999) 195–204. http://dx.doi.org/10.1083/jcb.147.1.195CrossrefGoogle Scholar

About the article

Published Online: 2011-07-23

Published in Print: 2011-09-01


Citation Information: Cellular and Molecular Biology Letters, ISSN (Online) 1689-1392, DOI: https://doi.org/10.2478/s11658-011-0014-z.

Export Citation

© 2011 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Daisuke Kyuno
World Journal of Gastroenterology, 2014, Volume 20, Number 31, Page 10813
[2]
Yosuke Hashimoto, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi, and Masuo Kondoh
Annals of the New York Academy of Sciences, 2017, Volume 1397, Number 1, Page 5
[3]
Theodore G. Gabig, Wayne C. Waltzer, Terry Whyard, and Victor Romanov
Biochemical and Biophysical Research Communications, 2016, Volume 478, Number 2, Page 887
[4]
Tsuyoshi Kono, Masuo Kondoh, Daisuke Kyuno, Tatsuya Ito, Yasutoshi Kimura, Masafumi Imamura, Takayuki Kohno, Takumi Konno, Tomohisa Furuhata, Norimasa Sawada, Koichi Hirata, and Takashi Kojima
Pharmacology Research & Perspectives, 2015, Volume 3, Number 6, Page e00196
[5]
Masayuki Someya, Takashi Kojima, Marie Ogawa, Takafumi Ninomiya, Kazuaki Nomura, Akira Takasawa, Masaki Murata, Satoshi Tanaka, Tsuyoshi Saito, and Norimasa Sawada
Cell and Tissue Research, 2013, Volume 354, Number 2, Page 481
[6]
Abbey Y. Kardys, Dhruba J. Bharali, and Shaker A. Mousa
Journal of Nanotechnology, 2013, Volume 2013, Page 1
[7]
Norimasa Sawada
Pathology International, 2013, Volume 63, Number 1, Page 1
[8]
Takashi Kojima, Daisuke Kyuno, and Norimasa Sawada
Expert Opinion on Therapeutic Targets, 2012, Volume 16, Number 9, Page 881
[9]
Marie Ogawa, Takashi Kojima, Masayuki Someya, Kazuaki Nomura, Akira Takasawa, Masaki Murata, Satoshi Tanaka, Tsuyoshi Saito, and Norimasa Sawada
Histochemistry and Cell Biology, 2012, Volume 138, Number 2, Page 323
[10]
A. Neesse, H. Griesmann, T.M. Gress, and P. Michl
Archives of Biochemistry and Biophysics, 2012, Volume 524, Number 1, Page 64
[11]
Daisuke Kyuno, Takashi Kojima, Tatsuya Ito, Hiroshi Yamaguchi, Mitsuhiro Tsujiwaki, Akira Takasawa, Masaki Murata, Satoshi Tanaka, Koichi Hirata, and Norimasa Sawada
Cell and Tissue Research, 2011, Volume 346, Number 3, Page 369

Comments (0)

Please log in or register to comment.
Log in